Customer Publication

Targeted Tumor Therapy by Rubia Tinctorum L.: Analytical Character­ization of Hydroxyan­thraquinones and Investigation of Their Selective Cytotoxic, Adhesion and Migration Modulator Effects on Melanoma Cell Lines

Authors: E. Lajkó et al.

Journal: Cancer cell international (2015)

Institution: Semmelweis University

Research Areas: Cancer research, drug development

Cell Lines: A2058, HT168-M1, MRC-5 (Human melanoma cell lines (A2058, HT168-M1) Human fibroblast cells (MRC-5))

Summary: Our results highlight the effective and selective inhibitory activity of purpurin towards melanoma cells and its possible use as a targeted anticancer agent. The anthraquinones of the cytotoxic extract are suggested to apply in drug delivery systems as an anticancer drug

Keywords: HoloMonitor M4, Migration, Motility and motility speed, Hydroxyanthraquinone, Purpurin, Melanoma, Targeted therapy, HPLC–MS/MS, Cell adhesion, Migration, Impedimetry, Holographic microscope

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2